stars 1 stars 2 stars 3

XenTech is Biotech/Contract Research Organization (CRO) dedicated to translational research in oncology which offers preclinical services to evaluate the anti-cancer potential of drug candidates (PDX, CDX,...) In addition, XenTech develops internal R&D programs to correlate drug response with molecular features of tumors and identify cancer biomarkers and therapeutic targets.

XenTech Questions

The XenTech annual revenue was $6.6 million in 2026.

Marie Caussou is the Chief Financial Officer and Directeur Administratif et Financier of XenTech.

23 people are employed at XenTech.

XenTech is based in Evry, Ile de France.

The NAICS codes for XenTech are [5417, 541713, 54, 54171, 541].

The SIC codes for XenTech are [87, 873].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users